ISRG - Intuitive Surgical, Inc.
| Previous Close | 577.98 |
| Open | 573.66 |
| Bid | 550.00 x 800 |
| Ask | 584.95 x 900 |
| Day's Range | 560.75 - 574.20 |
| 52 Week Range | 393.57 - 581.12 |
| Volume | 562,723 |
| Avg. Volume | 724,824 |
| Market Cap | 64.748B |
| Beta (3Y Monthly) | 1.27 |
| PE Ratio (TTM) | 59.14 |
| EPS (TTM) | 9.49 |
| Earnings Date | Apr 18, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 578.06 |
- CNBC Videos•18 days ago
Intuitive Surgical CEO: Helping surgeons avoid harming healthy tissue
Jim Cramer talks with Intuitive Surgical President and CEO Gary Guthart to learn how one product is helping doctors perform minimally invasive procedures.
- Investor's Business Daily•3 days ago
IBD's Investing Podcast: How To Make More Money In The Stock Market With Stock Charts
Investing with IBD is a weekly podcast focused on helping investors learn how to make more money in the stock market by using stock charts to find top stocks.
- InvestorPlace•4 days ago
Why Marijuana REITs Are One of the Best Investments Today
Legal marijuana is on the brink of explosive growth. But there are two key hurdles to overcome… and marijuana REITs like Innovative Industrial Properties (NYSE:IIPR) are solving them both.For growers, it's not easy to produce high-grade marijuana. Nor is it cheap -- and getting that funding is tricky. Until the U.S. government removes marijuana from its list of Schedule I drugs -- the ones considered most dangerous, like heroin -- most banks want no part of it. (No matter how bright the future looks.)For investors, the options have been limited, as that Schedule I label prohibits most U.S. companies from listing on the NYSE or NASDAQ.InvestorPlace - Stock Market News, Stock Advice & Trading TipsNotice I said "most."IIPR stock is one of the few. Why can it list on those major stock exchanges? Because it never actually touches the plant. This is one of the smartest ways to invest in the exploding marijuana industry while it is still technically illegal federally. * Top 7 Service Sector Stocks That Will Pay You to Own Them Like all marijuana REITs, Innovative Industrial Properties simply plays landlord to the growers. Here's how it works: IIPR buys freestanding properties from medical marijuana growers licensed by their respective states. It then leases the properties back to the growers. This gives those growers an infusion of capital to expand their operations and increase production. In return, the REIT receives regular rent payments under a long-term lease.Pretty slick, huh? Wall Street is certainly taking notice:Institutional investors now hold 59% of IIPR stock. Big players like Vanguard, Blackrock, and Wellington were largely the ones to cash in when shares hit a new 52-week high on the company's March earnings report.But marijuana REITs are also popular among investors like you and me -- because of their unique business model, as well as their dividends.Take a look at Innovative Industrial Properties' earnings and you'll see its rental income is growing exponentially. Then, because of the REIT structure, at least 90% of that gets passed along to shareholders. Innovative Industrial Properties paid a $0.35 dividend in Q4 -- 40% higher than the previous year -- and it's already announced another dividend hike in Q1, to $0.45. That makes for a nice forward yield of over 2%. (This is even after the price of the stock nearly doubled since December.)IIPR is a great stock, and now everybody is finding that out.But I like to invest way BEFORE everyone jumps on board. Getting in before the crowd is how you make the big money. And that stock is up over 160% since I recommended it to my Investment Opportunities readers last August.Back in college, I bought a brand-new apparel stock called True Religion for $0.20 -- then it popped up above $20.That's actually what set me on my journey to New York City… my career with Charles Schwab, then my own firm, Penn Financial Group… and nowadays my newsletters, including Investment Opportunities.I got people into Intuitive Surgical (NASDAQ:ISRG) at $10. Now it's over $550. We saw GrubHub (NYSE:GRUB) go from $35 to $140.I like to wait a couple of months after the IPO before investing, to avoid early volatility. That's what I advised for Facebook (NASDAQ:FB), which did in fact make an early stumble before it went into the stratosphere. (I'm still waiting for Twitter (NYSE:TWTR) to "show us the money.")And now, I've got my eye on a company called Treehouse. The Next IIPR?Treehouse is one of the marijuana REITs I think you should put on your radar. It's an up-and-comer, and this one focuses on retail, in addition to cultivation facilities.On Monday, Treehouse announced that it had raised $45.5 million in a private deal. (And that was from a "federally-insured commercial bank" -- a great example of how marijuana REITs can break that funding barrier.) That's after the REIT raised $133 million in its spinoff from MedMen Enterprises (OTCMKTS:MMNFF) in January.Treehouse is looking to expand its lineup of cannabis retail and industrial facilities…… and I also think it's headed toward an IPO.That's right. Treehouse is still privately held, but maybe not for long.Large amounts of private fundraising tend to indicate a company is building toward its "exit" in the form of a public offering. One study from PitchBook found that venture capital-backed companies were raising an average of $108 million before an IPO.If the rumors start flying and you hear about Treehouse on TV, well… you heard it here first. I'll definitely be keeping an eye on this REIT -- and so should you.Now, don't get me wrong:If Treehouse goes public, it wouldn't necessarily be an automatic buy. There's some homework to do first: make sure the fundamentals back up the hype. And the timing has to be right.That's all part of my Cannabis Cash Calendar system, which I designed specifically for marijuana IPOs. The early results are impressive, if I do say so myself, including an 80% gainer in less than four months.I already have the date circled for my next recommendation -- just two weeks away, on April 4.You can get exclusive access to it as soon as it's released to my Investment Opportunities readers. Click here to learn more about this opportunity and how to get on the list to be notified.Even if you don't know a thing about the marijuana markets… even if you've never bought a stock before. You could take just a small stake, and potentially multiply that over the next 12 months. Click here for more on this incredible trend.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Financial Stocks to Invest In Today * 7 Single-Digit P/E Stocks With Massive Upside * 5 Chip Stocks on the Rise Compare Brokers The post Why Marijuana REITs Are One of the Best Investments Today appeared first on InvestorPlace.
- Zacks•6 days ago
Stock Market News For Mar 18, 2019
Markets closed in the green on Friday as optimism around a U.S. - China trade deal boosted investor sentiment.
- Zacks•6 days ago
Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright
Intuitive Surgical (ISRG) fortifies its foothold in the global robotic-surgery market.
- Barrons.com•6 days ago
Intuitive Surgical Faces New Competition and FDA Concerns
The Food and Drug Administration is now warning consumers about the use of robotic equipment for mastectomies and other cancer-related surgeries for women.
- Zacks•8 days ago
Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know
Intuitive Surgical (ISRG) closed at $558.29 in the latest trading session, marking a -0.08% move from the prior day.
- GlobeNewswire•9 days ago
U.S. FDA Clears da Vinci SP for Certain Transoral Otolaryngology Procedures
Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced it has received clearance for the da Vinci SP® surgical system for use in certain transoral otolaryngology procedures in adults. The FDA cleared the single port approach for lateral oropharyngectomy procedures (commonly referred to as radical tonsillectomy) and tongue base resection. "Today’s FDA clearance means surgeons can utilize da Vinci SP robotic-assisted surgery to conduct radical tonsillectomy and tongue base resection transorally,” said Gary Guthart, Intuitive CEO.
- Zacks•10 days ago
Top Stock Reports for Visa, Honeywell & Biogen
Top Stock Reports for Visa, Honeywell & Biogen
- Zacks•11 days ago
RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio
RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.
- Markit•12 days ago
See what the IHS Markit Score report has to say about Intuitive Surgical Inc.
Intuitive Surgical Inc NASDAQ/NGS:ISRGView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for ISRG with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ISRG. Money flowETF/Index ownership | NegativeETF activity is negative but appears to be improving. Over the last one-month, outflows of investor capital in ETFs holding ISRG totaled $3.09 billion. However, outflows appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Motley Fool•14 days ago
Better Buy: Align Technology vs. Intuitive Surgical
These two companies have been super-successful in their niche markets. But which is the better pick for long-term investors?
- TheStreet.com•18 days ago
Intuitive Surgical Could Trade Sideways Before Hitting All-Time Highs
During the advance, the rising 50-day moving average line acted as support, and dips toward the line were buying opportunities. The daily On-Balance-Volume (OBV) line rose with the price action and confirmed the rally. Prices declined -- but notice how long ISRG stayed above the rising 200-day moving average line.
- Simply Wall St.•19 days ago
What Should Investors Know About Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Future?
Based on Intuitive Surgical, Inc.'s (NASDAQ:ISRG) earnings update on 31 December 2018, it seems that analyst expectations are fairly bearish, with earnings expected to grow by 4.4% in the upcomingRead More...
- Zacks•29 days ago
Intuitive Surgical (ISRG) Up 2.9% Since Last Earnings Report: Can It Continue?
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•last month
Intuitive Surgical (ISRG) Gains As Market Dips: What You Should Know
In the latest trading session, Intuitive Surgical (ISRG) closed at $549.87, marking a +0.04% move from the previous day.
- TechCrunch•last month
Robotics, AR and VR are poised to reshape healthcare, starting in the operating room
About 20 years ago, a medical device startup called Intuitive Surgical debutedthe da Vinci robot and changed surgical practices in operating rooms acrossthe United States
- Motley Fool•last month
3 Medical Device Companies for Your Watchlist
Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
- GlobeNewswire•last month
Report: Developing Opportunities within Pivotal Software, Ecolab, PDC Energy, Intuitive Surgical, Ducommun, and Hurco Companies — Future Expectations, Projections Moving into 2019
NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- American City Business Journals•last month
Only five T. Rowe Price U.S. mutual funds saw positive returns in 2018
Baltimore-based T. Rowe Price's funds, and the stock market overall, were hit hard by the stock market's dramatic plunge in December.
- Zacks•last month
Intuitive Surgical Gets FDA Nod for Ion Endoluminal System
The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Market Realist•last monthDruckenmiller Was Betting on These Top Names in Q4
Where Druckenmiller Suggests Investing amid Market Fluctuation(Continued from Prior Part)Druckenmiller’s top buysIn this article, we’ll discuss Stanley Druckenmiller’s top buys in the fourth quarter. Druckenmiller seemed to be positive on
- GlobeNewswire•last month
U. S. FDA Grants Clearance for Ion by Intuitive
Intuitive Surgical, Inc. (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) cleared the Ion™ endoluminal system to enable minimally invasive biopsy in the peripheral lung. Lung cancer is the world’s leading cause of cancer deaths. “Early lung cancer diagnosis can save lives.
- Simply Wall St.•last month
Will Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Earnings Grow Over The Next Few Years?
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! The latest earnings announcement Intuitive Surgical, Inc. (NASDAQ:ISRG) released inRead More...
- Motley Fool•last month
The Subtle Signal That the Bull Market Could Soon End
The current bull market is near the end of its 10th year. But this indicator could mean that it's near the end -- period.
